These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38922592)

  • 1. Pneumonia Risk, Antipsychotic Dosing, and Anticholinergic Burden in Schizophrenia.
    Luykx JJ; Correll CU; Manu P; Tanskanen A; Hasan A; Tiihonen J; Taipale H
    JAMA Psychiatry; 2024 Oct; 81(10):967-975. PubMed ID: 38922592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Effectiveness of Antipsychotics in Patients With Schizophrenia Spectrum Disorder.
    Hamina A; Taipale H; Lieslehto J; Lähteenvuo M; Tanskanen A; Mittendorfer-Rutz E; Tiihonen J
    JAMA Netw Open; 2024 Oct; 7(10):e2438358. PubMed ID: 39382894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotics Use Is Associated With Greater Adherence to Cardiometabolic Medications in Patients With Schizophrenia: Results From a Nationwide, Within-subject Design Study.
    Solmi M; Tiihonen J; Lähteenvuo M; Tanskanen A; Correll CU; Taipale H
    Schizophr Bull; 2022 Jan; 48(1):166-175. PubMed ID: 34286338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in Finland.
    Tiihonen J; Tanskanen A; Bell JS; Dawson JL; Kataja V; Taipale H
    Lancet Psychiatry; 2022 May; 9(5):353-362. PubMed ID: 35334224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of discontinuation of atypical antipsychotics in the province of Québec: A retrospective prescription claims database analysis.
    Moisan J; Grégoire JP
    Clin Ther; 2010; 32 Suppl 1():S21-31. PubMed ID: 20152549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world effectiveness of antipsychotic doses for relapse prevention in patients with first-episode schizophrenia in Finland: a nationwide, register-based cohort study.
    Taipale H; Tanskanen A; Correll CU; Tiihonen J
    Lancet Psychiatry; 2022 Apr; 9(4):271-279. PubMed ID: 35182475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotic medications and the progression of upper respiratory infection to pneumonia in patients with schizophrenia.
    Chang CK; Chen PH; Pan CH; Su SS; Tsai SY; Chen CC; Kuo CJ
    Schizophr Res; 2020 Aug; 222():327-334. PubMed ID: 32507380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of Antipsychotic Polypharmacy Versus Monotherapy in a Nationwide Cohort of 61,889 Patients With Schizophrenia.
    Taipale H; Tanskanen A; Tiihonen J
    Am J Psychiatry; 2023 May; 180(5):377-385. PubMed ID: 36945825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of Antipsychotic Use After Clozapine Discontinuation: A Real-World Study Across Antipsychotics.
    Stam N; Taipale H; Tanskanen A; Isphording L; Okhuijsen-Pfeifer C; Schuiling-Veninga CCM; Bos JHJ; Bijker BJ; Tiihonen J; Luykx JJ
    Clin Transl Sci; 2020 Nov; 13(6):1170-1177. PubMed ID: 32441836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia.
    Tiihonen J; Mittendorfer-Rutz E; Majak M; Mehtälä J; Hoti F; Jedenius E; Enkusson D; Leval A; Sermon J; Tanskanen A; Taipale H
    JAMA Psychiatry; 2017 Jul; 74(7):686-693. PubMed ID: 28593216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic Use and Risk of Low-Energy Fractures in People With Schizophrenia: A Nationwide Nested Case-Control Study in Finland.
    Solmi M; Lähteenvuo M; Correll CU; Tanskanen A; Tiihonen J; Taipale H
    Schizophr Bull; 2023 Jan; 49(1):78-89. PubMed ID: 36334051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-Generation Antipsychotics and Pneumonia-Related Hospitalizations.
    Milano VR; Kayhart BM; Morgan RJ; DeSimone DC; Mara KC; Leung JG
    Prim Care Companion CNS Disord; 2020 Aug; 22(4):. PubMed ID: 32767873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world effectiveness of antidepressants, antipsychotics and their combinations in the maintenance treatment of psychotic depression. Evidence from within-subject analyses of two nationwide cohorts.
    Taipale H; Lieslehto J; Lähteenvuo M; Hamina A; Tanskanen A; Mittendorfer-Rutz E; Paljärvi T; Solmi M; Cipriani A; Correll CU; Tiihonen J
    World Psychiatry; 2024 Jun; 23(2):276-284. PubMed ID: 38727044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Pharmacological Treatments and Hospitalization and Death in Individuals With Amphetamine Use Disorders in a Swedish Nationwide Cohort of 13 965 Patients.
    Hartikainen M; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Lähteenvuo M; Tiihonen J
    JAMA Psychiatry; 2023 Jan; 80(1):31-39. PubMed ID: 36383348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal Doses of Specific Antipsychotics for Relapse Prevention in a Nationwide Cohort of Patients with Schizophrenia.
    Taipale H; Tanskanen A; Luykx JJ; Solmi M; Leucht S; Correll CU; Tiihonen J
    Schizophr Bull; 2022 Jun; 48(4):774-784. PubMed ID: 35524479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].
    Bret P; Bonnet F; Bret MC; Jaffré A
    Encephale; 2002; 28(4):329-42. PubMed ID: 12232542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease.
    Koponen M; Taipale H; Lavikainen P; Tanskanen A; Tiihonen J; Tolppanen AM; Ahonen R; Hartikainen S
    J Alzheimers Dis; 2017; 56(1):107-118. PubMed ID: 27935554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors, Incidence, and Outcomes of Neuroleptic Malignant Syndrome on Long-Acting Injectable vs Oral Antipsychotics in a Nationwide Schizophrenia Cohort.
    Guinart D; Taipale H; Rubio JM; Tanskanen A; Correll CU; Tiihonen J; Kane JM
    Schizophr Bull; 2021 Oct; 47(6):1621-1630. PubMed ID: 34013325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.